TDL tbg diagnostics limited

News: TDL Tbg Diagnostics Says Group Total Revenues Of $2.5 Mil During Q1 Ended 31 March, page-4

  1. 103 Posts.
    lightbulb Created with Sketch. 16
    There's a long history, but in short, they had a wee bit of apparently accidental insider trading due to executive incompetence in discussing information that was not released to market but which appeared on an open forum; after which the people in question stated to the ASX that they did not know it was not closed comms. This is what initially prompted the suspension, but subsequent to that the ASX has found several other apparent irregularities in accounts, announcements, reports and intercompany communications (where shares are owned intermingled with each other, particularly with Medigien and TBD offshoots with associated exec staff and majority shareholders); whereby one might suggest that there's some closed shop benefit stuff going on that benefits the few, but not overall shareholders. ASX appears to be onto this and is hence giving TDL a hard time...anyway, that's my interpretation. Further of note, TDL CEO, Jitto has form in having a company suspended and then delisted as can occur at the 24 mth suspension point. See Lanka graphite. What happens to any leftover assets at that point is anyone's guess but given that intercompany charges (for things such as supply of raw materials between TDL and Medigen and related entities) amazingly appear to equal profits at every turn, there's little to no likelihood of TDL making a profit. My opinion is that they will never come out if suspension and at the 24 mth time point for that will be delisted from ASX. Personally I think this is deliberate strategy by CEO and board due to Medigen / majority shareholders benefiting from the intercompany dealings...not a great scenario, but there you go.regards,
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.